Barclays downgrades Array Technologies on weak growth outlook, margin strain
Go back to Barclays downgrades Array Technologies on weak growth outlook, margin strain| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 8.00 +0.34 (4.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.66 | 52 Week High | $7.27 | |||
| Open | $7.75 | 52 Week Low | $2.39 | |||
| Day High | $8.05 | P/E | N/A | |||
| Day Low | $7.57 | EPS | $-0.61 | |||
| Volume | 8,650,112 | |||||
| NYSE Arca Tech 100 ETF (NASDAQ: NXT) | Delayed: 125.90 +2.59 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.31 | 52 Week High | $25.39 | |||
| Open | $127.08 | 52 Week Low | $13.13 | |||
| Day High | $127.08 | P/E | N/A | |||
| Day Low | $119.02 | EPS | $0.00 | |||
| Volume | 4,068,929 | |||||
